1/44
testing for biomarker (3)
take sample
chemical and biochemical analysis to detect biomarkers
compare to references
plasma vs. serum
serum has clotting factors,
plasma has been treated with anticoagulants
serum = plasma - fibrinogen
Blue cap
reversible inhibition of clotting
clotting tests
yellow cap
allows clots,
serum for analysis of soluble components
pink/ purple cap
irreversible inhibition of clotting
blood cell/ plts analysis
green cap
anticoagulant
hormone/chromosome analysis
Grey cap
halts metabolism
analysis of energy sources, glucose
diagnostic biomarkers
they detect disease/ conditions
monitoring biomarkers
to assess status of disease
prognostic biomarkers
they predict disease progression
risk biomarkers
to see the transition from healthy to diseased
how do biomarkers levels change with extensive cell damage?
intracellular molecules (cell type specific) released
how do biomarkers levels change with cell proliferation?
increased markers of cell growth / rapid proliferation produced by cells
how do biomarkers levels change with enzyme induction?
increased expression of cell specific membranes
how do biomarkers levels change with duct obstruction?
blocked flow of molecules
increased in blood
spectroscopy with analysis of markers
colorimetric assays, chemical rxns, increased enzyme activity
chromatography with analysis of markers
molecule separation based on size
mass spectrometry with analysis of markers
molecule identification based on mass
immunoassays with analysis of markers
molecule identification based on molecular sequence/strructure
detected w/ antibodies
molecular techniques with analysis of markers
DNA/RNA sequencing to identify infection and genetic markers
POCT
point of care testing
patient present
rapid turnaround
non-laboratory
Clinical Biochemistry Department
labs
greater range of test
automated
Good Biomarkers should have:
specificity
biological understanding
reproducibility
efficient
cost effective
feasible sample collection
better than gold standard
sensitivity
pre- analytical factors affecting test result
technical - correct patient and correct labelling of sample
biological - age, gender, mass, ethnicity
analytical factors affecting test result
accuracy and precision
post analytical factors affecting test result
reporting, transmission, transcript, clinical decision
how is reference range calculated
μ ± 2SD
Liver Functions (4)
blood proteins production- albumin, clotting factors
bile production
bilirubin excretion- haem breakdown
phagocytosis of bacteria- via kupffer cells
metabolism and detox in the liver
glycogen → glucose
fatty acid metabolism -ketone production
a.a. metabolism - ammonia→ urea
pre-hepatic with bilirubin as a biomarker
high serum of unconjugated bilirubin
other LFT normal
eg. haemolytic disease
hepatic with bilirubin as a biomarker
high serum of conjugated bilirubin
liver enzymes elevated, liver damage
eg. hepatitis
post-hepatic with bilirubin as a biomarker
high serum of conjugated bilirubin
blockage of bile flow-cholestasis
eg. gallstones
LFT meaning
liver function test
elevated unconjugated bilirubin means…
increased bilirubin synthesis
haemolytic disease
decreased conjugation by liver → genetic disease
neonatal jaundice
elevated conjugated bilirubin means…
hepatocellular disease → liver damage
cholestasis → blockage to flow of bile
decreased transport of conjugated bilirubin
acute liver disease is…
viral, toxic, due to alcohol consumption
liver inflammation
rapid onset
chronic liver disease is …
alcoholic hepatitis/cirrhosis, non-alcoholic steatohepatitis, autoimmune disorders, genetics
slow progression
causes of acute hepatitis
hep A, hep B, Hep C (viral)
Paracetamol (toxins)
causes of chronic hepatitis
ongoing hepatic necrosis & liver inflammation
ongoing over consumption of alcohol, some medications, recreational drugs
acute and chronic hepatitis change levels of:
increased ALT (alanine aminotransferase)
increased AST (aspartate aminotransferase)
increased conjugated bilirubin
what is cholestasis
a blockage in the bile duct, meaning bile flow is obstructed into duodenum
results in bile (w/ conjugated bilirubin) is absorbed into the blood →obstructive jaundice
intrahepatic cholestasis
structural liver tissue damage
decreased bile flow in absence of overt bile duct obstruction
accumulation of bile constituents in liver and blood
extrahepatic cholestasis
bile duct obstruction, eg. gallstones, malignancies, pancreatitis
increased ALP
increased conjugated bilirubin
Alkaline Phosphatase (ALP) found where
surface of hepatocyte
microvilli of bile canaliculi
ducts
Alkaline phosphatase (ALP) why would it be raised?
cholestasis
hepatic injury
infiltrative diseases, w/ tumours
growth spurts in adolescents
broken bones